Objective Compared to older Caucasians, older African Americans have higher risks of
developing Alzheimer disease (AD) and lower cerebrospinal fluid (CSF) tau biomarker levels. It …

Background African Americans (AA) are more likely to develop Alzheimer’s disease (AD)
than Caucasians (CC). Dietary modification may have the potential to reduce the risk of …

Background: The rate of AD for African Americans (AAs) is 64% higher than for non-Hispanic
White Americans (Whites). It is hypothesized that poor peripheral vascular function, in …

Research indicates that certain antihypertensive medications alter Alzheimer’s disease (AD)
biomarkers in Caucasians. The renin angiotensin system (RAS) regulates blood pressure (…

INTRODUCTION There remains an urgent need to identify preclinical pathophysiological
mechanisms of Alzheimer's disease (AD) development in high‐risk, racially diverse populations…

Introduction The 2019 novel coronavirus disease (COVID-19) pandemic has had devastating
consequences in the US, yet clinical research on its natural history and transmission …

Background Black individuals (BIs) are at an increased risk of Alzheimer’s disease (AD) than
white individuals (WIs), which is partially explained by increased prevalence of vascular risk…

Background An estimated 2.7 million US older adults self‐identify as a sexual and/or gender
minority (SGM; ie, lesbian, gay, bisexual, transgender, and/or queer), a numbers that will …

Background Alzheimer’s disease (AD) incidence among Black/African Americans (B/AA) is
64% higher than non‐Hispanic Whites (NHW). Studies show CSF total and phosphorylated …

Background Clinicians and researchers utilize neuroimaging (NI) biomarkers of Alzheimer’s
disease (AD) at an increasing rate. It is crucial that we determine whether these biomarkers …